These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16311418)

  • 41. European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas.
    Raverot G; Burman P; McCormack A; Heaney A; Petersenn S; Popovic V; Trouillas J; Dekkers OM;
    Eur J Endocrinol; 2018 Jan; 178(1):G1-G24. PubMed ID: 29046323
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The molecular pathogenesis of pituitary tumors: implications for clinical management.
    Dworakowska D; Grossman AB
    Minerva Endocrinol; 2012 Jun; 37(2):157-72. PubMed ID: 22691889
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pituitary carcinoma occurring as middle ear tumor.
    Wilson DF
    Otolaryngol Head Neck Surg; 1982; 90(5):665-6. PubMed ID: 6819532
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term survival with ACTH-secreting carcinoma of the pituitary: a case report and review of the literature.
    Landman RE; Horwith M; Peterson RE; Khandji AG; Wardlaw SL
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3084-9. PubMed ID: 12107205
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contemporary issues in the evaluation and management of pituitary adenomas.
    Pekic S; Stojanovic M; Popovic V
    Minerva Endocrinol; 2015 Dec; 40(4):307-19. PubMed ID: 25900682
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MR imaging features of thyrotropin-secreting pituitary adenomas at initial presentation.
    Sarlis NJ; Gourgiotis L; Koch CA; Skarulis MC; Brucker-Davis F; Doppman JL; Oldfield EH; Patronas NJ
    AJR Am J Roentgenol; 2003 Aug; 181(2):577-82. PubMed ID: 12876051
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bibliography. Current World Literature. Endocrine tumors.
    Curr Opin Oncol; 2000 Jan; 12(1):B12-8. PubMed ID: 10687738
    [No Abstract]   [Full Text] [Related]  

  • 48. Late development of intraventricular papillary pituitary carcinoma after irradiation of prolactinoma.
    Tena-Suck ML; Salinas-Lara C; Sánchez-García A; Rembao-Bojórquez D; Ortiz-Plata A
    Surg Neurol; 2006 Nov; 66(5):527-33; discussion 533. PubMed ID: 17084204
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pathobiology of pituitary adenomas and carcinomas.
    Scheithauer BW; Gaffey TA; Lloyd RV; Sebo TJ; Kovacs KT; Horvath E; Yapicier O; Young WF; Meyer FB; Kuroki T; Riehle DL; Laws ER
    Neurosurgery; 2006 Aug; 59(2):341-53; discussion 341-53. PubMed ID: 16883174
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term outcome and MGMT as a predictive marker in 24 patients with atypical pituitary adenomas and pituitary carcinomas given treatment with temozolomide.
    Bengtsson D; Schrøder HD; Andersen M; Maiter D; Berinder K; Feldt Rasmussen U; Rasmussen ÅK; Johannsson G; Hoybye C; van der Lely AJ; Petersson M; Ragnarsson O; Burman P
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1689-98. PubMed ID: 25646794
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intramedullary spinal cord metastasis. Case report.
    Bizzozero L; Ferrara M; Villa F; Fontana R; Brusamolino R; Collice M
    J Neurosurg Sci; 1994 Sep; 38(3):193-5. PubMed ID: 7782867
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnosis & management of pituitary tumors.
    Weinstein J; Isaacs S; Shore D; Blevins LS
    Compr Ther; 1997 Sep; 23(9):594-604. PubMed ID: 9285160
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nasopharyngeal presentation of pituitary tumors. Differential diagnosis and treatment.
    van der Lely AJ; Knegt PP; Stefanko SZ; Tanghe HL; Singh R; Lamberts SW
    J Clin Endocrinol Metab; 1992 Apr; 74(4):811-3. PubMed ID: 1548346
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ACTH-producing pituitary tumors.
    Grua JR; Nelson DH
    Endocrinol Metab Clin North Am; 1991 Jun; 20(2):319-62. PubMed ID: 1652434
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A case of symptomatic pituitary metastases from renal cell carcinoma].
    Kamoshima Y; Terasaka S; Hamauchi S; Kobayashi H; Endo S; Kanno Y; Kimachi K; Houkin K
    No Shinkei Geka; 2011 Oct; 39(10):999-1004. PubMed ID: 21972190
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pituitary tumors.
    Mehta GU; Jane JA
    Curr Opin Neurol; 2012 Dec; 25(6):751-5. PubMed ID: 23108246
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Malignant prolactinoma: a rare case report.
    Trivedi P; Gupta A; Pasricha S; Patel D
    Neurol India; 2010; 58(5):778-80. PubMed ID: 21045511
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multiple endocrine neoplasia type 1-associated thyrotropin-producing pituitary carcinoma: report of a probable de novo example.
    Scheithauer BW; Kovacs K; Nose V; Lombardero M; Osamura YR; Lloyd RV; Horvath E; Pagenstecher A; Bohl JE; Tews DS
    Hum Pathol; 2009 Feb; 40(2):270-8. PubMed ID: 18755492
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pathological changes after radiotherapy for primary pituitary carcinoma: a case report.
    Yamashita H; Nakagawa K; Tago M; Nakamura N; Shiraishi K; Yamauchi N; Ohtomo K
    J Neurooncol; 2005 Nov; 75(2):209-14. PubMed ID: 16283444
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term response of pituitary carcinoma to temozolomide. Report of two cases.
    Fadul CE; Kominsky AL; Meyer LP; Kingman LS; Kinlaw WB; Rhodes CH; Eskey CJ; Simmons NE
    J Neurosurg; 2006 Oct; 105(4):621-6. PubMed ID: 17044568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.